Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1998-12-30
|
pubmed:abstractText |
Nausea and vomiting following antineoplastic therapy in patients receiving chemotherapy remains a problem. To prevent nausea and vomiting due to antineoplastic therapy, many types of drugs have been used. Ondansetron and the combination metoclopramide-diphenhydramine have been widely used in children. In this prospective randomized study these drugs were compared both for their efficacy and side-effects in children treated with antineoplastic chemotherapy (with and without cisplatin) the number of chemotherapy courses being equal in both groups. Ondansetron gave complete anti-emetic cover in five of nine courses in patients treated with cisplatin. Metoclopramide-diphenhydramine gave complete anti-emetic cover in one out of nine courses, and 17 out of 23 courses in patients treated without cisplatin. Metoclopramide-diphenhydramine produced side effects in nine courses whereas ondansetron produced side-effects in three courses. CONCLUSION: Ondansetron appeared to be superior to metoclopramide-diphenhydramine in the control of emesis induced by chemotherapy regimens containing cisplatin. The results of the present prospective randomized study indicate that ondansetron is a useful anti-emetic in the treatment of chemotherapy-induced emesis.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiemetics,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Diphenhydramine,
http://linkedlifedata.com/resource/pubmed/chemical/Metoclopramide,
http://linkedlifedata.com/resource/pubmed/chemical/Ondansetron
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0340-6199
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
157
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
806-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9809818-Antiemetics,
pubmed-meshheading:9809818-Antineoplastic Agents,
pubmed-meshheading:9809818-Child,
pubmed-meshheading:9809818-Diphenhydramine,
pubmed-meshheading:9809818-Drug Therapy, Combination,
pubmed-meshheading:9809818-Female,
pubmed-meshheading:9809818-Humans,
pubmed-meshheading:9809818-Male,
pubmed-meshheading:9809818-Metoclopramide,
pubmed-meshheading:9809818-Nausea,
pubmed-meshheading:9809818-Ondansetron,
pubmed-meshheading:9809818-Prospective Studies,
pubmed-meshheading:9809818-Treatment Outcome,
pubmed-meshheading:9809818-Vomiting
|
pubmed:year |
1998
|
pubmed:articleTitle |
Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
|
pubmed:affiliation |
Department of Paediatric Oncology, Gülhane Military Medical Academy and Medical School, Ankara, Turkey. vedatnur@superonline.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|